Incidence of RSV-related hospitalizations for ARIs, including CAP: Data from the German prospective ThEpiCAP study
Older adults in Germany experience a high burden of RSV-related ARI hospitalizations, including CAP, underscoring RSV vaccination's potential utility for this population.
Authors
- Christian Theilacker (ORCID: https://orcid.org/0000-0003-0821-9202)
- Jeffrey Vietri (ORCID: https://orcid.org/0000-0002-5610-3098)
- Liz Wang
- Sonal Uppal
- Jo Southern (ORCID: https://orcid.org/0000-0001-6172-7092)
- Caihua Liang (ORCID: https://orcid.org/0009-0004-8375-631X)
- Juliane Ankert
- Stefan Hagel (ORCID: https://orcid.org/0000-0003-2999-6131)
- Mathias Wilhelm Pletz (ORCID: https://orcid.org/0000-0001-8157-2753)
- Bradford D. Gessner (ORCID: https://orcid.org/0000-0002-6216-7194)
- Elizabeth Begier (ORCID: https://orcid.org/0000-0002-1287-5416)
- Claudia Schwarz
- Qing Liu (ORCID: https://orcid.org/0000-0003-3733-9078)
- Christof von Eiff (ORCID: https://orcid.org/0000-0002-7821-2359)
- Lea Johanna Bayer
Institutions
- Pfizer (United States) (US)
- Pfizer (Germany) (DE)
- Jena University Hospital (DE)
- Pfizer (Ireland) (IE)
- Friedrich Schiller University Jena (DE)
Publication Details
- Journal
- Journal of Infection
- Published
- 2025-02-12
- DOI
- https://doi.org/10.1016/j.jinf.2025.106440
- Citations
- 8
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 10.83
Funders
- Pfizer